Search

A highly sensitive, reversible, reusable and fluorogenic "turn-on" probe (HBTC) is fabricated for the sole detection of Al3+. On incremental addition of Al3+ in a solution of HBTC in ACN : H2O (4 : 1), a sharp "turn-on" emission enhancement is observed at 480 nm. The reversibility of the probe (HBTC) was displayed on the addition of F− solution. The detection limit is found to be of the order of 10−9 M which suggests that HBTC can detect Al3+ at a very minute level. The mechanism for Al3+ detection in ACN : H2O (4 : 1) is attributed to forbidding C＝N isomerization and ESIPT process simultaneously turning on the chelation-enhanced fluorescence process. The reusability and real-time application of the probe are also studied. Bioimaging study reveals that HBTC can detect Al3+ in human breast cancer cells (MDA-MB-231). Electronic structure of the probe is explained by density functional theory. [ABSTRACT FROM AUTHOR]

A phenylazo appended ortho‐vanillin Schiff base scaffold (HAZ) has been used for selective colorimetric sensing of Cu2+ in semi‐aqueous medium (methanol–water, 1:1, v/v) in the presence of 16 cations and 20 anions, and the limit of detection is 1.8 × 10−7 M. The structures of HAZ and Cu (II) complex, [Cu(AZ)2], have been characterised by spectroscopic data (UV–Vis, Fourier transform infrared and electron paramagnetic resonance) and established by the single crystal X‐ray diffraction measurement. The Job's plot from the absorption studies has also confirmed the 1:2 stoichiometry of Cu2+:HAZ. The absorption spectrum of [Cu (AZ)2] has returned to the spectrum of HAZ on the addition of Na2EDTA solution which is again recovered upon the addition of Cu2+ solution. Discrete Fourier transform computations were carried out using the coordinates of the X‐ray structures of the compounds, and the molecular functions were used to correlate the solution spectroscopic properties. In addition to this, the probe is treated on MDA‐MB 231 breast cancer cells to check the cytotoxicity. The probe is used for the detection of trace quantity of Cu2+ in the cancer cell. [ABSTRACT FROM AUTHOR]